Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNEX.L Regulatory News (NEX)

  • There is currently no data for NEX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - National Express Group plc

20 Jan 2022 09:49

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Marathon Asset Management Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

National Express Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

19 January 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

Ordinary shares

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

10,687,799

1.74

0

0

(2) Cash-settled derivatives:

 

0

0

0

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0

0

0

 

TOTAL:

10,687,799*

1.74

0

0

* Marathon Asset Management Limited does not have discretion regarding voting decisions in respect of 978,091 shares that are included in the total above.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ordinary Shares

Purchase

3,559

2.6357

Ordinary Shares

Purchase

4,654

2.6038

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

20 January 2022

Contact name:

Kevin Kot

Telephone number*:

0207 497 2211

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk

View source version on businesswire.com: https://www.businesswire.com/news/home/20220120005478/en/

Copyright Business Wire 2022

Date   Source Headline
20th Jun 202311:21 amRNSChange of Name
16th Jun 20232:51 pmRNSHolding(s) in Company
14th Jun 20239:02 amRNSHolding(s) in Company
2nd Jun 20237:00 amRNSDirector/PDMR Shareholding
10th May 20234:11 pmRNSResult of AGM
10th May 20237:00 amRNSChange of Name
19th Apr 20237:00 amRNSQ1 Trading Update
14th Apr 202312:43 pmRNSHolding(s) in Company
3rd Apr 20239:16 amRNSTotal Voting Rights
30th Mar 20233:54 pmRNSHolding(s) in Company
30th Mar 20231:21 pmRNSHolding(s) in Company
30th Mar 20231:17 pmRNSHolding(s) in Company
28th Mar 20234:33 pmRNSHolding(s) in Company
28th Mar 20232:11 pmRNSDirector/PDMR Shareholding
27th Mar 20235:34 pmRNSHolding(s) in Company
27th Mar 202310:12 amRNS2022 Annual Report and Notice of 2023 AGM
20th Mar 20234:52 pmRNSHolding(s) in Company
17th Mar 20234:32 pmRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNSFinal Results
9th Feb 20237:00 amRNSNotice of FY22 Results Presentation
23rd Jan 20237:00 amRNSEUR1 Billion German Rail Contract Award
3rd Jan 202311:02 amRNSTotal Voting Rights
5th Dec 20227:00 amRNSAPPOINTMENT OF GROUP CFO
20th Oct 20227:00 amRNSTrading Statement
3rd Oct 20229:15 amRNSDirector/PDMR Shareholding
3rd Oct 20229:11 amRNSTotal Voting Rights
8th Sep 20227:01 amRNSAPPOINTMENT OF INTERIM GROUP CFO
8th Sep 20227:00 amRNSAPPOINTMENT OF CHAIR DESIGNATE
5th Sep 20224:22 pmRNSDirector/PDMR Shareholding
15th Aug 202212:54 pmRNSDirector/PDMR Shareholding
10th Aug 20227:04 amRNSDirectorate Change
4th Aug 20223:27 pmRNSHolding(s) in Company
1st Aug 202211:32 amRNSDirector/PDMR Shareholding
28th Jul 20227:00 amRNSHalf-year Report
1st Jul 20228:31 amRNSTotal Voting Rights
28th Jun 20221:01 pmRNSHolding(s) in Company
23rd Jun 202210:23 amRNSDirector/PDMR Shareholding
13th Jun 20221:43 pmRNSPublication of a Prospectus
10th Jun 20223:43 pmRNSDirector/PDMR Shareholding
9th Jun 20223:16 pmRNSHolding(s) in Company
7th Jun 20227:00 amRNSTrading Statement
24th May 20221:56 pmRNSForm 8.3 - Stagecoach Group plc
24th May 20221:48 pmRNSForm 8.3 - National Express Group plc
23rd May 20223:52 pmRNSForm 8.3 - STAGECOACH GROUP PLC
23rd May 20223:49 pmRNSForm 8.3 - National Express Group plc
23rd May 20223:31 pmRNSForm 8.3 -National Express Group plc
23rd May 20223:20 pmRNSForm 8.3 - National Express Group plc
23rd May 20221:51 pmGNWForm 8.3 - National Express Group PLC
23rd May 20221:29 pmRNSForm 8.3 - National Express Group Plc
23rd May 202211:35 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - National Express Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.